Publications by authors named "C Capitant"
Article Synopsis
- Vaccination against hepatitis A (HAV) and hepatitis B (HBV) is strongly recommended for men who have sex with men (MSM), with a study evaluating vaccine uptake during the ANRS IPERGAY pre-exposure prophylaxis (PrEP) trial.
- Out of 427 MSM participants analyzed, a significant number were non-immune to HAV (50.4%), with high vaccination uptake: 96.1% received at least one dose of HAV vaccine, and 97.6% of HBV non-immune participants received at least one HBV vaccine dose.
- Overall, complete vaccination resulted in a high rate of immunity, showing that PrEP visits are crucial for offering vaccination to at-risk MSM who are
Objective: High rates of sexually transmitted infections (STIs) have been reported among pre-exposure prophylaxis (PrEP) users. We wished to assess the incidence and risk factors for recurrent STIs.
Design: The ANRS IPERGAY trial was a prospective study investigating PrEP among MSM and transgender women in outpatient clinics in France and Canada.
Background: We used the Agence nationale de Recherches sur le sida et les hépatites virales (ANRS)-IPERGAY trial to qualitatively and quantitatively measure drug use among men who have sex with men under preexposure prophylaxis using 2 different methods, to better understand and collectively respond to risky practices.
Method: We included 69 volunteers of the ANRS-IPERGAY trial. We measured drug use by 2 methods: (1) drug detection by hair analysis and (2) reported drug use by self-reported drug consumption.
High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Pre-exposure Prophylaxis Trial.
Clin Infect Dis
October 2021
Background: Mycoplasma genitalium (MG) is an emerging pathogen among men who have sex with men (MSM) with raising rates of antibiotic resistance. This study assessed the prevalence and incidence of MG infection in MSM enrolled in the open-label phase of the ANRS IPERGAY trial with on-demand tenofovir disoproxil fumarate/emtricitabine for human immunodeficiency virus prevention and the impact of doxycycline post-exposure prophylaxis (PEP).
Methods: 210 subjects were tested at baseline and at 6 months by real-time PCR assays for MG detection in urine samples and oropharyngeal and anal swabs.
We assessed the coverage of sex acts by event-driven pre-exposure prophylaxis (ED-PrEP) over a 2-month period in 54 participants in the open label phase of the ANRS Ipergay trial. Participants received an electronic monitoring system device to record bottle openings. Self-questionnaires collected daily information on PrEP intake and sexual behavior.
View Article and Find Full Text PDF